WuXi PharmaTech (WX) Tops Q1 EPS by 1c; Guides Q2 Sales

WuXi PharmaTech (NYSE: WX) reported Q1 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $118 million versus the consensus estimate of $114.19 million.

Sees Q2 2012 revenue of $124-$129 million, versus the consensus of $118.03 million.

For earnings history and earnings-related data on WuXi PharmaTech (WX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Arena Group to rename as Paradium.AI, ticker changing to PAAI
• CoStar Group acquires Zonda for $800M, adding new home data